SGD has announced Alain Comel’s appointment as Chief Financial Officer for the future pharmaceutical entity.
Responsible for setting up the financial department of the new pharmaceutical entity, Alain Comel will be part of the Executive Committee and will support the growth’s strategy of the future entity.